317 related articles for article (PubMed ID: 27401566)
21. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
Strobel J; Müller F; Zolk O; Endreß B; König J; Fromm MF; Maas R
Amino Acids; 2013 Oct; 45(4):989-1002. PubMed ID: 23864433
[TBL] [Abstract][Full Text] [Related]
22. Multiple organic cation transporters contribute to the renal transport of sulpiride.
Li L; Weng Y; Wang W; Bai M; Lei H; Zhou H; Jiang H
Biopharm Drug Dispos; 2017 Dec; 38(9):526-534. PubMed ID: 28926871
[TBL] [Abstract][Full Text] [Related]
23. Organic cation transporter-mediated renal secretion of ipratropium and tiotropium in rats and humans.
Nakanishi T; Haruta T; Shirasaka Y; Tamai I
Drug Metab Dispos; 2011 Jan; 39(1):117-22. PubMed ID: 20962061
[TBL] [Abstract][Full Text] [Related]
24. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
25. Genetic and Epigenetic Regulation of Organic Cation Transporters.
Kölz C; Schaeffeler E; Schwab M; Nies AT
Handb Exp Pharmacol; 2021; 266():81-100. PubMed ID: 33674913
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the role of organic cation transporter 2 (OCT2) in the renal transport of guanfacine, a selective α2A-adrenoreceptor agonist.
Li X; Sun X; Chen J; Lu Y; Zhang Y; Wang C; Li J; Zhang Q; Zhao D; Chen X
Xenobiotica; 2015 Jan; 45(1):88-94. PubMed ID: 25115365
[TBL] [Abstract][Full Text] [Related]
27. The Impact of Genetic Polymorphisms in Organic Cation Transporters on Renal Drug Disposition.
Zazuli Z; Duin NJCB; Jansen K; Vijverberg SJH; Maitland-van der Zee AH; Masereeuw R
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927790
[TBL] [Abstract][Full Text] [Related]
28. Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride.
Li LP; Song FF; Weng YY; Yang X; Wang K; Lei HM; Ma J; Zhou H; Jiang HD
Br J Pharmacol; 2016 Aug; 173(16):2543-54. PubMed ID: 27324234
[TBL] [Abstract][Full Text] [Related]
29. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
[TBL] [Abstract][Full Text] [Related]
30. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.
Belzer M; Morales M; Jagadish B; Mash EA; Wright SH
J Pharmacol Exp Ther; 2013 Aug; 346(2):300-10. PubMed ID: 23709117
[TBL] [Abstract][Full Text] [Related]
31. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
[TBL] [Abstract][Full Text] [Related]
32. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.
Yang J; Kalogerou M; Gallacher J; Sampson JR; Shen MH
Eur J Cancer; 2013 Apr; 49(6):1479-90. PubMed ID: 23228442
[TBL] [Abstract][Full Text] [Related]
33. Functional characterization of the organic cation transporters (OCTs) in human airway pulmonary epithelial cells.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
Biochim Biophys Acta; 2015 Jul; 1848(7):1563-72. PubMed ID: 25883089
[TBL] [Abstract][Full Text] [Related]
34. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
Higgins JW; Bedwell DW; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2012 Jun; 40(6):1170-7. PubMed ID: 22407892
[TBL] [Abstract][Full Text] [Related]
35. Interaction of beta-blockers with the renal uptake transporter OCT2.
Bachmakov I; Glaeser H; Endress B; Mörl F; König J; Fromm MF
Diabetes Obes Metab; 2009 Nov; 11(11):1080-3. PubMed ID: 19740083
[TBL] [Abstract][Full Text] [Related]
36. Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation.
Shen H; Liu T; Jiang H; Titsch C; Taylor K; Kandoussi H; Qiu X; Chen C; Sukrutharaj S; Kuit K; Mintier G; Krishnamurthy P; Fancher RM; Zeng J; Rodrigues AD; Marathe P; Lai Y
Drug Metab Dispos; 2016 Feb; 44(2):238-49. PubMed ID: 26608080
[TBL] [Abstract][Full Text] [Related]
37. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
[TBL] [Abstract][Full Text] [Related]
38. New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2.
Ciarimboli G; Holle SK; Vollenbröcker B; Hagos Y; Reuter S; Burckhardt G; Bierer S; Herrmann E; Pavenstädt H; Rossi R; Kleta R; Schlatter E
Mol Pharm; 2011 Feb; 8(1):270-9. PubMed ID: 21077648
[TBL] [Abstract][Full Text] [Related]
39. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
Nies AT; Koepsell H; Damme K; Schwab M
Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis.
Clarke JD; Dzierlenga AL; Nelson NR; Li H; Werts S; Goedken MJ; Cherrington NJ
Diabetes; 2015 Sep; 64(9):3305-13. PubMed ID: 26016715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]